View in EDS HTML Full Text PDF Full Text

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.

Saved in:
Bibliographic Details
Title: Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.
Authors: Reid P; Division of Rheumatology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA., Sandigursky S; Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, NY, USA., Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lopez-Olivo MA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Safa H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cytryn S; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA., Efuni E; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA., Buni M; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pavlick A; Medical Oncology, Weill Cornell Medical Center, New York, NY, USA., Krogsgaard M; Perlmutter Cancer Center, Department of Pathology, NYU Langone Health, New York, NY, USA., Abu-Shawer O; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA., Altan M; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weber JS; Perlmutter Cancer Center, Department of Medicine, NYU Langone Health, New York, NY, USA., Rahma OE; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Suarez-Almazor ME; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abdel-Wahab N; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.
Source: Oncoimmunology [Oncoimmunology] 2023 Oct 30; Vol. 12 (1), pp. 2261264. Date of Electronic Publication: 2023 Oct 30 (Print Publication: 2023).
Publication Type: Observational Study; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38126033
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reid+P%22">Reid P</searchLink>; Division of Rheumatology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Sandigursky+S%22">Sandigursky S</searchLink>; Division of Rheumatology, Department of Medicine, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Song+J%22">Song J</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lopez-Olivo+MA%22">Lopez-Olivo MA</searchLink>; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Safa+H%22">Safa H</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Cytryn+S%22">Cytryn S</searchLink>; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA.<br /><searchLink fieldCode="AU" term="%22Efuni+E%22">Efuni E</searchLink>; Division of Internal Medicine, Department of Medicine, NYU Langone Health, New York, TX, USA.<br /><searchLink fieldCode="AU" term="%22Buni+M%22">Buni M</searchLink>; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pavlick+A%22">Pavlick A</searchLink>; Medical Oncology, Weill Cornell Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Krogsgaard+M%22">Krogsgaard M</searchLink>; Perlmutter Cancer Center, Department of Pathology, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Abu-Shawer+O%22">Abu-Shawer O</searchLink>; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Altan+M%22">Altan M</searchLink>; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Weber+JS%22">Weber JS</searchLink>; Perlmutter Cancer Center, Department of Medicine, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rahma+OE%22">Rahma OE</searchLink>; Department of Internal Medicine, Harvard Medical School, Boston, MA, USA.; Department of Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Suarez-Almazor+ME%22">Suarez-Almazor ME</searchLink>; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Diab+A%22">Diab A</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Abdel-Wahab+N%22">Abdel-Wahab N</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Rheumatology and Rehabilitation, Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2023 Oct 30; Vol. 12 (1), pp. 2261264. <i>Date of Electronic Publication: </i>2023 Oct 30 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Observational Study; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38126033
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2023.2261264
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2261264
    Titles:
      – TitleFull: Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reid P
      – PersonEntity:
          Name:
            NameFull: Sandigursky S
      – PersonEntity:
          Name:
            NameFull: Song J
      – PersonEntity:
          Name:
            NameFull: Lopez-Olivo MA
      – PersonEntity:
          Name:
            NameFull: Safa H
      – PersonEntity:
          Name:
            NameFull: Cytryn S
      – PersonEntity:
          Name:
            NameFull: Efuni E
      – PersonEntity:
          Name:
            NameFull: Buni M
      – PersonEntity:
          Name:
            NameFull: Pavlick A
      – PersonEntity:
          Name:
            NameFull: Krogsgaard M
      – PersonEntity:
          Name:
            NameFull: Abu-Shawer O
      – PersonEntity:
          Name:
            NameFull: Altan M
      – PersonEntity:
          Name:
            NameFull: Weber JS
      – PersonEntity:
          Name:
            NameFull: Rahma OE
      – PersonEntity:
          Name:
            NameFull: Suarez-Almazor ME
      – PersonEntity:
          Name:
            NameFull: Diab A
      – PersonEntity:
          Name:
            NameFull: Abdel-Wahab N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 10
              Text: 2023 Oct 30
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1